The drugmaker Mylan announced on Wednesday that it was acquiring Agila Specialties Private, an Indian manufacturer of generic injectable drugs, for $1.6 billion in cash. The move would double Mylan’s presence in the injectable-drug market, a fast-growing segment of the generic drug industry that nevertheless has been beset by major quality and supply problems.
— From wire reports